http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03095464-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44bf9a00ecec82758eb1b0e889f28599
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-3353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
filingDate 2003-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a711162f828f06dd7986428aa67dc00c
publicationDate 2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03095464-A1
titleOfInvention Phosphatidyl oligo glycerins and structural analogs
abstract The invention relates to novel structural analogs to phosphatidyl oligo glycerins. These compounds can be used, in particular, for producing liposomes having a long circulation time with or without thermolability. The invention also relates to liposomes containing compounds of the aforementioned type and to medicament compositions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7452888-B2
priorityDate 2002-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19835611-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4699990-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19622224-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6344576-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03028701-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87932465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128387026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87932467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231810264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231810244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87932464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248040992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230042981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68905301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249139909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87932469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249026042

Total number of triples: 40.